Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
Steve Tuplin, VP, Global Disease Area Head – Hematology and ai Oncology at Roche, shared on LinkedIn:
”The contrast between my last visit at ASH 15 years ago and this year’s meeting was striking.
It gave me a profoundly valuable sense of where haematology is heading now.
I am particularly impressed by how much the standards for treating Haemophilia A have evolved in that time.
After connecting with colleagues and hearing from the wider haemophilia A community during this period, it’s clear that the conversation continues to move beyond bleeding control, and we’re collectively taking a bigger leap into tackling the broader challenges faced by people with this disease.
As my colleague John Pasi,Global Franchise Head, Haematology and Rare Blood Diseases, Product Development at Roche, says in this recent Roche article, even as science advances, people still navigate physical, emotional, and logistical hurdles that shape “daily, different, and ever-changing realities.”
We’ve seen remarkable progress in haemophilia A care in recent years. Still, its future lies in a combination of sustained innovation, personalised approaches, and dedication to meeting the evolving needs of people living with the disease.
Read John’s full perspective on how we should combine scientific excellence with a commitment to global health equity to reshape the future of care.”

Stay updated with Hemostasis Today.
-
May 12, 2026, 14:57Marcel Miron-Celis: The Largest Cohort Ever Studied on Perioperative Management of Thrombotic APS
-
May 12, 2026, 14:53Wrapping up the 2026 CE Meetings Season with Our Physical Therapists CE Meeting in Chicago – Hemophilia Alliance
-
May 12, 2026, 14:53Melissa Hollo: Using AI to Identify Iron Deficiency Anemia Months Earlier
-
May 12, 2026, 14:50Giuseppe Biondi Zoccai: Comparing vFFR-Guided and FFR-Guided Revascularization in Intermediate Coronary Lesions
-
May 12, 2026, 14:48Happy Mother’s Day to All the Amazing GT Moms- Glanzmann’s Research Foundation, Inc.
-
May 12, 2026, 14:46Ifeanyichukwu Ifechidere: DOAC Interference in Coagulation Tests – Are You Spotting It?
-
May 12, 2026, 14:46Yusra Iqbal: What Hemophilia Teaches Us About Modern Hematology
-
May 12, 2026, 14:45Seema Dawood: Platelet Production and the Role of Thrombopoietin
-
May 12, 2026, 14:43Abdou Salam Poutougnigni: Honored to Represent Fondation Pierre Fabre at the Africa CDC Sickle Cell Disease Validation Conference